CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
open- label, single arm, multicenter clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System in NYHA Class III Heart...
Louisville, Kentucky, United States and 74 other locations
of the Cordella™ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial).The study contains of 5 a...
Louisville, Kentucky, United States and 62 other locations
The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease...
Phase 3
Louisville, Kentucky, United States and 467 other locations
This trial will evaluate Orbital Atherectomy compared to conventional balloon angioplasty technique for the treatment of severely calcified lesions p...
Louisville, Kentucky, United States and 103 other locations
2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart...
Louisville, Kentucky, United States and 122 other locations
This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardio...
Phase 3
Louisville, Kentucky, United States and 521 other locations
The primary objective of this study is to evaluate the effectiveness of early treatment with evolocumab plus routine lipid management vs routine lipi...
Phase 4
Louisville, Kentucky, United States and 119 other locations
The primary objective of this study is to assess the efficacy of a single dose of ravulizumab IV compared with placebo in reducing the risk of the cl...
Phase 3
Louisville, Kentucky, United States and 173 other locations
) including coronary heart disease (CHD) death, ischemic stroke, myocardial infarction (MI), acute limb ischemia or major amputatio...
Phase 3
Louisville, Kentucky, United States and 334 other locations
The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. ...
Phase 3
Louisville, Kentucky, United States and 638 other locations
Clinical trials
Research sites
Resources
Legal